David Thal

30PUBLICATIONS
201CO-AUTHORS
Biomolecular modelling and designMedical infection agents (incl. prions)PharmacogenomicsToxicology (incl. clinical toxicology)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Jul 02, 2026
Next-generation chemogenetic inhibition using a brain-permeant non-prescription agent.

|Jun 30, 2026
Low Agonism and Balanced Pathway Modulation Distinguish an M1 Muscarinic Receptor Positive Allosteric Modulator Lacking Cholinergic Adverse Effects.

|Dec 29, 2025
The Concise Guide to PHARMACOLOGY 2025/26: G protein-coupled receptors.

Stephen P H Alexander, Anthony P Davenport, Eamonn Kelly

|Nov 24, 2025
Structure-guided allosteric modulation of the delta opioid receptor.

Jesse I Mobbs, M Deborah Nguyen, Owindeep Deo

|Nov 12, 2025
Structural basis for Porcupine inhibition.

Katrina A Black, Jesse I Mobbs, Hariprasad Venugopal

|Aug 18, 2025
Molecular basis of ligand binding and receptor activation at the human A<sub>3</sub> adenosine receptor.

Liudi Zhang, Jesse I Mobbs, Felix M Bennetts

Pageof 5

Frequent Collaborators

17 joint publications

Celine Valant

14 joint publications

Arthur Christopoulos

11 joint publications

Jesse Mobbs

8 joint publications

Hariprasad Venugopal